logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Molnupiravir Off-White To White Powder CAS 2349386-89-4 API In Pharmacy

Molnupiravir Off-White To White Powder CAS 2349386-89-4 API In Pharmacy

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 2349386-89-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 2349386-89-4 API in pharmacy

,

Molnupiravir Powder

,

Molnupiravir API In Pharmacy

CAS NO::
2349386-89-4
Appearance ::
Off-white To White Powder
Molecular Formula::
C13H19N3O7
Molecular Weight::
329.306
EINECS NO::
604-604-1
MDL NO::
N/A
CAS NO::
2349386-89-4
Appearance ::
Off-white To White Powder
Molecular Formula::
C13H19N3O7
Molecular Weight::
329.306
EINECS NO::
604-604-1
MDL NO::
N/A
Molnupiravir Off-White To White Powder CAS 2349386-89-4 API In Pharmacy

Product Description:

Product Name: Molnupiravir CAS NO: 2349386-89-4

 

Synonyms:

EIDD-2801;

((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate;

 

Chemical & Physical Properties:

Appearance : Off-white to white powder

Assay : ≥99.0%

Loss on drying ≤0.5%

Residue of ignition ≤0.1%

single impurity ≤0.2%

single impurity ≤1.0%

 

Molnupiravir (EIDD-2801) is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. EIDD-2801 has been shown to improve pulmonary function, decrease body weight loss and reduce the amount of virus in the lung. In addition to activity against coronaviruses, EIDD-2801, in laboratory studies, has demonstrated activity against seasonal and bird influenza, respiratory syncytial virus, chikungunya virus, Ebola virus, Venezuelan equine encephalitis virus, and Eastern equine encephalitis virus. EIDD-2801 is a prodrug of EIDD-1931.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.